BSG and viral infectious disease: CD147 can also interact directly with the RBD domain of SARS-CoV-2 S protein because humanized anti-CD147 antibody can competitively inhibit the binding of S protein and CD147 and inhibit virus infection in host cells, suggesting that CD147 may also be one of the receptors mediating SARS-CoV-2 infection (39).